A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective

Introduction: Pheochromocytomas (PCC) and paragangliomas (PGL) are rare endocrine tumours. The objective of this study was to describe our experience with these two entities in a Singapore population. Methods: We identified patients with positive histopathological confirmations of PCC and PGL who we...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingshan Lee, Leon Yuan Rui Tan, Shaikh Abdul Kader Kamaldeen Abdul Shakoor
Format: Article
Language:English
Published: Wolters Kluwer – Medknow Publications 2022-11-01
Series:Singapore Medical Journal
Subjects:
Online Access:https://journals.lww.com/10.11622/smedj.2021135
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861013826502656
author Yingshan Lee
Leon Yuan Rui Tan
Shaikh Abdul Kader Kamaldeen Abdul Shakoor
author_facet Yingshan Lee
Leon Yuan Rui Tan
Shaikh Abdul Kader Kamaldeen Abdul Shakoor
author_sort Yingshan Lee
collection DOAJ
description Introduction: Pheochromocytomas (PCC) and paragangliomas (PGL) are rare endocrine tumours. The objective of this study was to describe our experience with these two entities in a Singapore population. Methods: We identified patients with positive histopathological confirmations of PCC and PGL who were treated at a tertiary Singapore hospital between January 2000 and December 2015. The results were analysed for clinical presentations, treatment and long-term outcomes. Results: A total of 27 cases (20 PCC, 7 PGL) were identified over a 15-year period. One case of PGL developed bilateral disease on follow-up. There were 17 male and 10 female patients with a median age of 57 (range 24–77) years. A positive family history was uncommon and present in only 3.7% of patients. Uniquely, the top three presenting symptoms were abdominal discomfort, palpitations and diaphoresis. Despite adequate preoperative preparation, intraoperative haemodynamic instability occurred in 70.4% and early postoperative hypotension occurred in 11.1% of patients. After surgery, hypertension was resolved in 41.2% (7/17) and diabetes mellitus in 60% (3/5). Disease recurrence was reported in 22.2% and distant metastases in 14.8%. At the end of the follow-up period (median 35 [range 3–148] months), 70.4% were still alive. Conclusion: PCC and PGL can present with a wide range of symptoms. Intraoperative haemodynamic instability was frequent despite good preoperative preparation. Disease recurrences and metastasis occurred in up to one-fifth of the patients. Genetic screening should be offered to patients with PCC and PGL.
format Article
id doaj-art-1e7c04d3eaa740a98d76d452317e78c7
institution Kabale University
issn 0037-5675
2737-5935
language English
publishDate 2022-11-01
publisher Wolters Kluwer – Medknow Publications
record_format Article
series Singapore Medical Journal
spelling doaj-art-1e7c04d3eaa740a98d76d452317e78c72025-02-10T05:47:16ZengWolters Kluwer – Medknow PublicationsSingapore Medical Journal0037-56752737-59352022-11-01631164965810.11622/smedj.2021135A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspectiveYingshan LeeLeon Yuan Rui TanShaikh Abdul Kader Kamaldeen Abdul ShakoorIntroduction: Pheochromocytomas (PCC) and paragangliomas (PGL) are rare endocrine tumours. The objective of this study was to describe our experience with these two entities in a Singapore population. Methods: We identified patients with positive histopathological confirmations of PCC and PGL who were treated at a tertiary Singapore hospital between January 2000 and December 2015. The results were analysed for clinical presentations, treatment and long-term outcomes. Results: A total of 27 cases (20 PCC, 7 PGL) were identified over a 15-year period. One case of PGL developed bilateral disease on follow-up. There were 17 male and 10 female patients with a median age of 57 (range 24–77) years. A positive family history was uncommon and present in only 3.7% of patients. Uniquely, the top three presenting symptoms were abdominal discomfort, palpitations and diaphoresis. Despite adequate preoperative preparation, intraoperative haemodynamic instability occurred in 70.4% and early postoperative hypotension occurred in 11.1% of patients. After surgery, hypertension was resolved in 41.2% (7/17) and diabetes mellitus in 60% (3/5). Disease recurrence was reported in 22.2% and distant metastases in 14.8%. At the end of the follow-up period (median 35 [range 3–148] months), 70.4% were still alive. Conclusion: PCC and PGL can present with a wide range of symptoms. Intraoperative haemodynamic instability was frequent despite good preoperative preparation. Disease recurrences and metastasis occurred in up to one-fifth of the patients. Genetic screening should be offered to patients with PCC and PGL.https://journals.lww.com/10.11622/smedj.2021135adrenal incidentalomaneuroendocrine carcinomaparagangliomapheochromocytoma
spellingShingle Yingshan Lee
Leon Yuan Rui Tan
Shaikh Abdul Kader Kamaldeen Abdul Shakoor
A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
Singapore Medical Journal
adrenal incidentaloma
neuroendocrine carcinoma
paraganglioma
pheochromocytoma
title A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
title_full A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
title_fullStr A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
title_full_unstemmed A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
title_short A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective
title_sort 15 year pheochromocytoma and paraganglioma experience in a single centre a singapore perspective
topic adrenal incidentaloma
neuroendocrine carcinoma
paraganglioma
pheochromocytoma
url https://journals.lww.com/10.11622/smedj.2021135
work_keys_str_mv AT yingshanlee a15yearpheochromocytomaandparagangliomaexperienceinasinglecentreasingaporeperspective
AT leonyuanruitan a15yearpheochromocytomaandparagangliomaexperienceinasinglecentreasingaporeperspective
AT shaikhabdulkaderkamaldeenabdulshakoor a15yearpheochromocytomaandparagangliomaexperienceinasinglecentreasingaporeperspective
AT yingshanlee 15yearpheochromocytomaandparagangliomaexperienceinasinglecentreasingaporeperspective
AT leonyuanruitan 15yearpheochromocytomaandparagangliomaexperienceinasinglecentreasingaporeperspective
AT shaikhabdulkaderkamaldeenabdulshakoor 15yearpheochromocytomaandparagangliomaexperienceinasinglecentreasingaporeperspective